ArticleRheumatology and therapy2020

Clinical Utility and Cost Savings in Predicting Inadequate Response to Anti-TNF Therapies in Rheumatoid Arthritis.

Martin J Bergman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.